Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,598.00 INR | +2.12% |
|
+9.89% | -9.90% |
30/06 | India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma | RE |
27/06 | Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market | RE |
Main competitors
Consensus (Composite) | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
₹2,717.76 | +6.83% | 17 | |||||||
$952.05 | +20.41% | 27 | |||||||
$169.31 | +7.37% | 23 | |||||||
$209.12 | +7.24% | 27 | |||||||
DKK 644.77 | +41.54% | 22 | |||||||
CHF 301.38 | +14.59% | 20 | |||||||
- | CHF 121.01 | -2.75% | 19 | ||||||
GBX 184.23 | +27.83% | 20 | |||||||
$101.79 | +21.15% | 24 | |||||||
$313.88 | +4.5% | 28 | |||||||
$29.14 | +13.05% | 23 | |||||||
$116.96 | +2.11% | 26 | |||||||
$500.23 | +4.32% | 28 | |||||||
€112.64 | +33.84% | 23 | |||||||
$57.1 | +17.68% | 21 | |||||||
GBX 16.61 | +14.2% | 19 | |||||||
JP¥8,360.71 | +21.89% | 14 | |||||||
CN¥65.72 | +14.09% | 18 | |||||||
JP¥4,946.56 | +14.08% | 16 | |||||||
Average | 1,048.47 | +14.95% | 22 | ||||||
Weighted average by Cap. | 600.36 | +16.08% | 23 |
- Stock Market
- Equities
- MANKIND Stock
- Sector Mankind Pharma Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition